Leonteq Securities AG’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Leonteq Securities AG's NVS Position: Q1 2022 in Review
Leonteq Securities AG sold out of Novartis (NVS) in Q1 2022, closing a stake of 840 shares — an estimated $73.5K sold.
Leonteq Securities AG first reported a position in NVS in Q4 2020 and held it in 5 quarters. The position peaked at $116K in Q1 2021. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.
- Leonteq Securities AG reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
- Leonteq Securities AG sold 840 Novartis shares in Q1 2022, an estimated $73.5K.
- Leonteq Securities AG first reported a position in Novartis in Q4 2020 and held it in 5 quarters.
- Leonteq Securities AG's Novartis position peaked at $116K in Q1 2021.
- 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.
Based on Leonteq Securities AG's 13F filing for Q1 2022, filed 26 Mar 2026.